Using teledermoscopy and AI to improve skin cancer diagnosis
Teledermoscopy and Artificial Intelligence: Effects of Implementation in Clinical Practice
This study is testing if using teledermoscopy and artificial intelligence can improve how doctors diagnose skin cancer and reduce the chances of missing any cases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Lund) |
| Trial ID | NCT05033678 on ClinicalTrials.gov |
What this trial studies
This study investigates the implementation of teledermoscopy in clinical practice to assess its impact on referral patterns, diagnostic accuracy, and the risk of undetected skin cancers. It consists of two parts: the first part evaluates the safety and effectiveness of teledermoscopy compared to conventional care, while the second part examines the integration of artificial intelligence algorithms to enhance diagnostic accuracy among teledermoscopic assessors. Data will be collected through teledermoscopic referrals, patient records, and questionnaires from both primary care and dermatology clinics. Statistical analyses will compare consultation rates and diagnostic outcomes before and after the introduction of teledermoscopy.
Who should consider this trial
Good fit: Ideal candidates are patients with skin lesions who have been assessed by a physician and are referred for teledermoscopy.
Not a fit: Patients under 15 years old or those with poor-quality images that cannot be assessed will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and improved diagnosis of skin cancers, potentially saving lives.
How similar studies have performed: Other studies have shown promising results with teledermoscopy and AI in dermatology, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Has a skin lesion assessed by a physician during a visit * The physician decides to create a teledermoscopy referral Exclusion Criteria: * inability or unwillingness to participate in the study * the patient is younger than 15 years old * Images of such bad quality they cannot be assessed
Where this trial is running
Lund
- Department of dermatology, Skane University Hospital — Lund, Sweden (Recruiting)
Study contacts
- Principal investigator: Asa Ingvar, PhD — Department of Dermatology, Skane University Hospital, Region Skane, Sweden
- Study coordinator: Asa Ingvar, PhD
- Email: asa.ingvar@skane.se
- Phone: +4646172243
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.